World Alzheimer's Month - Supporting development of medicines by qualification of biomarkers

View source ↗

Summary

EMA discusses aiding the development of medicines by qualifying biomarkers, highlighting regulatory qualification processes during World Alzheimer's Month.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease